Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 7.28 is 19% below its 5-year average of 9.01, near the low end of its 5-year range (7.19–12.66).
As of the fiscal period ended Tuesday, June 30, 2026. 11.33% below its 12-month average of 8.21.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 7.28.
QUICK RATIO (ACID-TEST)
7.28
QUICK RATIO (ACID-TEST) AVG TTM
8.21
QUICK RATIO (ACID-TEST) AVG 3Y
9.58
QUICK RATIO (ACID-TEST) AVG 5Y
9.01
QUICK RATIO (ACID-TEST) AVG 10Y
6.94
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-11.33%
CURRENT VS 3Y AVG
-23.97%
CURRENT VS 5Y AVG
-19.24%
CURRENT VS 10Y AVG
+4.92%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.28
median of 794 covered companies
CURRENT VS SECTOR MEDIAN
+121.96%
vs the sector median at left
Market Cap
$800.37M
Quick Ratio (Acid-Test)
3.15
TTM Avg
4.21
3Y Avg
3.84
5Y Avg
4.13
Market Cap
$796.08M
Quick Ratio (Acid-Test)
0.98
TTM Avg
0.95
3Y Avg
0.97
5Y Avg
0.95
Market Cap
$812.67M
Quick Ratio (Acid-Test)
14.93
TTM Avg
20.63
3Y Avg
16.30
5Y Avg
22.70
Market Cap
$792.28M
Quick Ratio (Acid-Test)
5.16
TTM Avg
4.89
3Y Avg
3.82
5Y Avg
4.31
Market Cap
$791.57M
Quick Ratio (Acid-Test)
3.86
TTM Avg
4.02
3Y Avg
3.56
5Y Avg
3.80
Market Cap
$777.94M
Quick Ratio (Acid-Test)
1.38
TTM Avg
2.71
3Y Avg
3.18
5Y Avg
5.09
Market Cap
$833.62M
Quick Ratio (Acid-Test)
7.96
TTM Avg
6.81
3Y Avg
6.62
5Y Avg
6.62
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| InMode Ltd. (INMD) | $804.16M | 7.28 | 8.21 | 9.58 | 9.01 |
| Ardelyx, Inc. (ARDX)vs › | $800.37M | 3.15 | 4.21 | 3.84 | 4.13 |
| AdaptHealth Corp. (AHCO)vs › | $796.08M | 0.98 | 0.95 | 0.97 | 0.95 |
| Jade Biosciences, Inc. (JBIO)vs › | $812.67M | 14.93 | 20.63 | 16.30 | 22.70 |
| Geron Corporation (GERN)vs › | $792.28M | 5.16 | 4.89 | 3.82 | 4.31 |
| Gyre Therapeutics, Inc. (GYRE)vs › | $791.57M | 3.86 | 4.02 | 3.56 | 3.80 |
| Apnimed, Inc. (APMD)vs › | $781.33M | N/A | N/A | N/A | N/A |
| Sana Biotechnology, Inc. (SANA)vs › | $777.94M | 1.38 | 2.71 | 3.18 | 5.09 |
| Beta Bionics, Inc. (BBNX)vs › | $833.62M | 7.96 | 6.81 | 6.62 | 6.62 |
| Pacific Biosciences of California, Inc. (PACB)vs › | $832.41M | 4.03 | 6.29 | 5.71 | 7.79 |
Quick Ratio
7.28
Excludes inventory
Current Ratio
8.18
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 7.28 |
| 2026-03-31 | 7.88 |
| 2025-12-31 | 8.61 |
| 2025-09-30 | 8.71 |
| 2025-06-30 | 8.58 |
| 2025-03-31 | 7.86 |
| 2024-12-31 | 9.38 |
| 2024-10-31 | 9.91 |
| 2024-06-30 | 8.09 |
| 2024-03-31 | 12.66 |
| 2023-12-31 | 12.48 |
| 2023-09-30 | 11.87 |
| 2023-06-30 | 11.21 |
| 2023-03-31 | 10.29 |
| 2022-12-31 | 7.19 |
| 2022-09-30 | 9.12 |
| 2022-06-30 | 8.27 |
| 2022-03-31 | 8.63 |
| 2021-12-31 | 8.66 |
| 2021-09-30 | 7.81 |
| 2021-06-30 | 8.49 |
| 2021-03-31 | 8.62 |
| 2020-12-31 | 7.84 |
| 2020-09-30 | 6.80 |
| 2020-06-30 | 7.81 |
| 2020-03-31 | 7.27 |
| 2019-12-31 | 6.27 |
| 2019-09-30 | 7.47 |
| 2019-06-30 | 3.89 |
| 2019-03-31 | 3.37 |
| 2018-12-31 | 2.41 |
| 2018-09-30 | 3.47 |
| 2018-06-30 | 3.12 |
| 2018-03-31 | 0.00 |
| 2017-12-31 | 2.39 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
